The global Inhaled Asthma Medications market was valued at US$ 16850 million in 2023 and is anticipated to reach US$ 24220 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.

Inhaled Asthma Medications Market

Inhaled asthma medications are a cornerstone of asthma management, delivering medication directly to the lungs for rapid and effective relief of symptoms. These medications include bronchodilators, such as short-acting beta-agonists (e.g., albuterol) for quick relief during asthma attacks, and long-acting beta-agonists (e.g., salmeterol) for ongoing control. Inhaled corticosteroids (e.g., fluticasone) are commonly used for long-term management to reduce inflammation and prevent exacerbations. Combination inhalers that include both a corticosteroid and a long-acting bronchodilator are also available for more comprehensive control. The inhalation route ensures high local drug concentration with minimal systemic side effects, enhancing efficacy and safety. Proper inhaler technique and adherence to prescribed treatment regimens are essential for optimal asthma control, reducing the frequency and severity of asthma symptoms, and improving overall quality of life for patients.

North American market for Inhaled Asthma Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Inhaled Asthma Medications is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Inhaled Asthma Medications include Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaled Asthma Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Asthma Medications.

The Inhaled Asthma Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Inhaled Asthma Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inhaled Asthma Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhaled Asthma Medications Market Report

Report Metric	Details
Report Name	Inhaled Asthma Medications Market
Accounted market size in 2023	US$ 16850 million
Forecasted market size in 2030	US$ 24220 million
CAGR	5.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Dry Powder Soft Mist
Segment by Application	Anti-inflammatory Bronchodilators Combination Therapy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled Asthma Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled Asthma Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Inhaled Asthma Medications Market growing?

Ans: The Inhaled Asthma Medications Market witnessing a CAGR of 5.4% during the forecast period 2024-2030.

What is the Inhaled Asthma Medications Market size in 2030?

Ans: The Inhaled Asthma Medications Market size in 2030 will be US$ 24220 million.

Who are the main players in the Inhaled Asthma Medications Market report?

Ans: The main players in the Inhaled Asthma Medications Market are Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma

What are the Application segmentation covered in the Inhaled Asthma Medications Market report?

Ans: The Applications covered in the Inhaled Asthma Medications Market report are Anti-inflammatory, Bronchodilators, Combination Therapy, Other

What are the Type segmentation covered in the Inhaled Asthma Medications Market report?

Ans: The Types covered in the Inhaled Asthma Medications Market report are Dry Powder, Soft Mist

1 Inhaled Asthma Medications Market Overview

1.1 Product Definition

1.2 Inhaled Asthma Medications by Type

1.2.1 Global Inhaled Asthma Medications Market Value Comparison by Type (2024-2030)

1.2.2 Dry Powder

1.2.3 Soft Mist

1.3 Inhaled Asthma Medications by Application

1.3.1 Global Inhaled Asthma Medications Market Value by Application (2024-2030)

1.3.2 Anti-inflammatory

1.3.3 Bronchodilators

1.3.4 Combination Therapy

1.3.5 Other

1.4 Global Inhaled Asthma Medications Market Size Estimates and Forecasts

1.4.1 Global Inhaled Asthma Medications Revenue 2019-2030

1.4.2 Global Inhaled Asthma Medications Sales 2019-2030

1.4.3 Global Inhaled Asthma Medications Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Inhaled Asthma Medications Market Competition by Manufacturers

2.1 Global Inhaled Asthma Medications Sales Market Share by Manufacturers (2019-2024)

2.2 Global Inhaled Asthma Medications Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Inhaled Asthma Medications Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Inhaled Asthma Medications, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Inhaled Asthma Medications, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Inhaled Asthma Medications, Product Type & Application

2.7 Global Key Manufacturers of Inhaled Asthma Medications, Date of Enter into This Industry

2.8 Global Inhaled Asthma Medications Market Competitive Situation and Trends

2.8.1 Global Inhaled Asthma Medications Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Inhaled Asthma Medications Players Market Share by Revenue

2.8.3 Global Inhaled Asthma Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Inhaled Asthma Medications Market Scenario by Region

3.1 Global Inhaled Asthma Medications Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Inhaled Asthma Medications Sales by Region: 2019-2030

3.2.1 Global Inhaled Asthma Medications Sales by Region: 2019-2024

3.2.2 Global Inhaled Asthma Medications Sales by Region: 2025-2030

3.3 Global Inhaled Asthma Medications Revenue by Region: 2019-2030

3.3.1 Global Inhaled Asthma Medications Revenue by Region: 2019-2024

3.3.2 Global Inhaled Asthma Medications Revenue by Region: 2025-2030

3.4 North America Inhaled Asthma Medications Market Facts & Figures by Country

3.4.1 North America Inhaled Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Inhaled Asthma Medications Sales by Country (2019-2030)

3.4.3 North America Inhaled Asthma Medications Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Inhaled Asthma Medications Market Facts & Figures by Country

3.5.1 Europe Inhaled Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Inhaled Asthma Medications Sales by Country (2019-2030)

3.5.3 Europe Inhaled Asthma Medications Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Inhaled Asthma Medications Market Facts & Figures by Region

3.6.1 Asia Pacific Inhaled Asthma Medications Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Inhaled Asthma Medications Sales by Region (2019-2030)

3.6.3 Asia Pacific Inhaled Asthma Medications Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Inhaled Asthma Medications Market Facts & Figures by Country

3.7.1 Latin America Inhaled Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Inhaled Asthma Medications Sales by Country (2019-2030)

3.7.3 Latin America Inhaled Asthma Medications Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Inhaled Asthma Medications Market Facts & Figures by Country

3.8.1 Middle East and Africa Inhaled Asthma Medications Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Inhaled Asthma Medications Sales by Country (2019-2030)

3.8.3 Middle East and Africa Inhaled Asthma Medications Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Inhaled Asthma Medications Sales by Type (2019-2030)

4.1.1 Global Inhaled Asthma Medications Sales by Type (2019-2024)

4.1.2 Global Inhaled Asthma Medications Sales by Type (2025-2030)

4.1.3 Global Inhaled Asthma Medications Sales Market Share by Type (2019-2030)

4.2 Global Inhaled Asthma Medications Revenue by Type (2019-2030)

4.2.1 Global Inhaled Asthma Medications Revenue by Type (2019-2024)

4.2.2 Global Inhaled Asthma Medications Revenue by Type (2025-2030)

4.2.3 Global Inhaled Asthma Medications Revenue Market Share by Type (2019-2030)

4.3 Global Inhaled Asthma Medications Price by Type (2019-2030)

5 Segment by Application

5.1 Global Inhaled Asthma Medications Sales by Application (2019-2030)

5.1.1 Global Inhaled Asthma Medications Sales by Application (2019-2024)

5.1.2 Global Inhaled Asthma Medications Sales by Application (2025-2030)

5.1.3 Global Inhaled Asthma Medications Sales Market Share by Application (2019-2030)

5.2 Global Inhaled Asthma Medications Revenue by Application (2019-2030)

5.2.1 Global Inhaled Asthma Medications Revenue by Application (2019-2024)

5.2.2 Global Inhaled Asthma Medications Revenue by Application (2025-2030)

5.2.3 Global Inhaled Asthma Medications Revenue Market Share by Application (2019-2030)

5.3 Global Inhaled Asthma Medications Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Teva Pharmaceutical

6.1.1 Teva Pharmaceutical Company Information

6.1.2 Teva Pharmaceutical Description and Business Overview

6.1.3 Teva Pharmaceutical Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Teva Pharmaceutical Inhaled Asthma Medications Product Portfolio

6.1.5 Teva Pharmaceutical Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Inhaled Asthma Medications Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Merck Inhaled Asthma Medications Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Roche

6.4.1 Roche Company Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Roche Inhaled Asthma Medications Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AstraZeneca Inhaled Asthma Medications Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Boehringer Ingelheim International

6.6.1 Boehringer Ingelheim International Company Information

6.6.2 Boehringer Ingelheim International Description and Business Overview

6.6.3 Boehringer Ingelheim International Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Boehringer Ingelheim International Inhaled Asthma Medications Product Portfolio

6.6.5 Boehringer Ingelheim International Recent Developments/Updates

6.7 Sanofi

6.7.1 Sanofi Company Information

6.7.2 Sanofi Description and Business Overview

6.7.3 Sanofi Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Sanofi Inhaled Asthma Medications Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 BD

6.8.1 BD Company Information

6.8.2 BD Description and Business Overview

6.8.3 BD Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.8.4 BD Inhaled Asthma Medications Product Portfolio

6.8.5 BD Recent Developments/Updates

6.9 Covis Pharma

6.9.1 Covis Pharma Company Information

6.9.2 Covis Pharma Description and Business Overview

6.9.3 Covis Pharma Inhaled Asthma Medications Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Covis Pharma Inhaled Asthma Medications Product Portfolio

6.9.5 Covis Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Inhaled Asthma Medications Industry Chain Analysis

7.2 Inhaled Asthma Medications Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Inhaled Asthma Medications Production Mode & Process

7.4 Inhaled Asthma Medications Sales and Marketing

7.4.1 Inhaled Asthma Medications Sales Channels

7.4.2 Inhaled Asthma Medications Distributors

7.5 Inhaled Asthma Medications Customers

8 Inhaled Asthma Medications Market Dynamics

8.1 Inhaled Asthma Medications Industry Trends

8.2 Inhaled Asthma Medications Market Drivers

8.3 Inhaled Asthma Medications Market Challenges

8.4 Inhaled Asthma Medications Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International

Sanofi

Covis Pharma

List of Tables

Table 1. Global Inhaled Asthma Medications Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Inhaled Asthma Medications Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Inhaled Asthma Medications Market Competitive Situation by Manufacturers in 2023

Table 4. Global Inhaled Asthma Medications Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Inhaled Asthma Medications Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Inhaled Asthma Medications Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Inhaled Asthma Medications Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Inhaled Asthma Medications Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Inhaled Asthma Medications, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Inhaled Asthma Medications, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Inhaled Asthma Medications, Product Type & Application

Table 12. Global Key Manufacturers of Inhaled Asthma Medications, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Inhaled Asthma Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Asthma Medications as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Inhaled Asthma Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Inhaled Asthma Medications Sales by Region (2019-2024) & (K Units)

Table 18. Global Inhaled Asthma Medications Sales Market Share by Region (2019-2024)

Table 19. Global Inhaled Asthma Medications Sales by Region (2025-2030) & (K Units)

Table 20. Global Inhaled Asthma Medications Sales Market Share by Region (2025-2030)

Table 21. Global Inhaled Asthma Medications Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Inhaled Asthma Medications Revenue Market Share by Region (2019-2024)

Table 23. Global Inhaled Asthma Medications Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Inhaled Asthma Medications Revenue Market Share by Region (2025-2030)

Table 25. North America Inhaled Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Inhaled Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 27. North America Inhaled Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 28. North America Inhaled Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Inhaled Asthma Medications Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Inhaled Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Inhaled Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 32. Europe Inhaled Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 33. Europe Inhaled Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Inhaled Asthma Medications Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Inhaled Asthma Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Inhaled Asthma Medications Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Inhaled Asthma Medications Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Inhaled Asthma Medications Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Inhaled Asthma Medications Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Inhaled Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Inhaled Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Inhaled Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Inhaled Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Inhaled Asthma Medications Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Inhaled Asthma Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Inhaled Asthma Medications Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Inhaled Asthma Medications Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Inhaled Asthma Medications Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Inhaled Asthma Medications Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Inhaled Asthma Medications Sales (K Units) by Type (2019-2024)

Table 51. Global Inhaled Asthma Medications Sales (K Units) by Type (2025-2030)

Table 52. Global Inhaled Asthma Medications Sales Market Share by Type (2019-2024)

Table 53. Global Inhaled Asthma Medications Sales Market Share by Type (2025-2030)

Table 54. Global Inhaled Asthma Medications Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Inhaled Asthma Medications Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Inhaled Asthma Medications Revenue Market Share by Type (2019-2024)

Table 57. Global Inhaled Asthma Medications Revenue Market Share by Type (2025-2030)

Table 58. Global Inhaled Asthma Medications Price (US$/Unit) by Type (2019-2024)

Table 59. Global Inhaled Asthma Medications Price (US$/Unit) by Type (2025-2030)

Table 60. Global Inhaled Asthma Medications Sales (K Units) by Application (2019-2024)

Table 61. Global Inhaled Asthma Medications Sales (K Units) by Application (2025-2030)

Table 62. Global Inhaled Asthma Medications Sales Market Share by Application (2019-2024)

Table 63. Global Inhaled Asthma Medications Sales Market Share by Application (2025-2030)

Table 64. Global Inhaled Asthma Medications Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Inhaled Asthma Medications Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Inhaled Asthma Medications Revenue Market Share by Application (2019-2024)

Table 67. Global Inhaled Asthma Medications Revenue Market Share by Application (2025-2030)

Table 68. Global Inhaled Asthma Medications Price (US$/Unit) by Application (2019-2024)

Table 69. Global Inhaled Asthma Medications Price (US$/Unit) by Application (2025-2030)

Table 70. Teva Pharmaceutical Company Information

Table 71. Teva Pharmaceutical Description and Business Overview

Table 72. Teva Pharmaceutical Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Teva Pharmaceutical Inhaled Asthma Medications Product

Table 74. Teva Pharmaceutical Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. GSK Inhaled Asthma Medications Product

Table 79. GSK Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Merck Inhaled Asthma Medications Product

Table 84. Merck Recent Developments/Updates

Table 85. Roche Company Information

Table 86. Roche Description and Business Overview

Table 87. Roche Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Roche Inhaled Asthma Medications Product

Table 89. Roche Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. AstraZeneca Inhaled Asthma Medications Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Boehringer Ingelheim International Company Information

Table 96. Boehringer Ingelheim International Description and Business Overview

Table 97. Boehringer Ingelheim International Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Boehringer Ingelheim International Inhaled Asthma Medications Product

Table 99. Boehringer Ingelheim International Recent Developments/Updates

Table 100. Sanofi Company Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Sanofi Inhaled Asthma Medications Product

Table 104. Sanofi Recent Developments/Updates

Table 105. BD Company Information

Table 106. BD Description and Business Overview

Table 107. BD Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. BD Inhaled Asthma Medications Product

Table 109. BD Recent Developments/Updates

Table 110. Covis Pharma Company Information

Table 111. Covis Pharma Description and Business Overview

Table 112. Covis Pharma Inhaled Asthma Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Covis Pharma Inhaled Asthma Medications Product

Table 114. Covis Pharma Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Inhaled Asthma Medications Distributors List

Table 118. Inhaled Asthma Medications Customers List

Table 119. Inhaled Asthma Medications Market Trends

Table 120. Inhaled Asthma Medications Market Drivers

Table 121. Inhaled Asthma Medications Market Challenges

Table 122. Inhaled Asthma Medications Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Inhaled Asthma Medications

Figure 2. Global Inhaled Asthma Medications Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Inhaled Asthma Medications Market Share by Type: 2023 & 2030

Figure 4. Dry Powder Product Picture

Figure 5. Soft Mist Product Picture

Figure 6. Global Inhaled Asthma Medications Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Inhaled Asthma Medications Market Share by Application: 2023 & 2030

Figure 8. Anti-inflammatory

Figure 9. Bronchodilators

Figure 10. Combination Therapy

Figure 11. Other

Figure 12. Global Inhaled Asthma Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Inhaled Asthma Medications Market Size (2019-2030) & (US$ Million)

Figure 14. Global Inhaled Asthma Medications Sales (2019-2030) & (K Units)

Figure 15. Global Inhaled Asthma Medications Average Price (US$/Unit) & (2019-2030)

Figure 16. Inhaled Asthma Medications Report Years Considered

Figure 17. Inhaled Asthma Medications Sales Share by Manufacturers in 2023

Figure 18. Global Inhaled Asthma Medications Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Inhaled Asthma Medications Players: Market Share by Revenue in Inhaled Asthma Medications in 2023

Figure 20. Inhaled Asthma Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Inhaled Asthma Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Inhaled Asthma Medications Sales Market Share by Country (2019-2030)

Figure 23. North America Inhaled Asthma Medications Revenue Market Share by Country (2019-2030)

Figure 24. United States Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Inhaled Asthma Medications Sales Market Share by Country (2019-2030)

Figure 27. Europe Inhaled Asthma Medications Revenue Market Share by Country (2019-2030)

Figure 28. Germany Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Inhaled Asthma Medications Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Inhaled Asthma Medications Revenue Market Share by Region (2019-2030)

Figure 35. China Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Inhaled Asthma Medications Sales Market Share by Country (2019-2030)

Figure 43. Mexico Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Inhaled Asthma Medications Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Inhaled Asthma Medications Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Inhaled Asthma Medications Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Inhaled Asthma Medications by Type (2019-2030)

Figure 53. Global Revenue Market Share of Inhaled Asthma Medications by Type (2019-2030)

Figure 54. Global Inhaled Asthma Medications Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Inhaled Asthma Medications by Application (2019-2030)

Figure 56. Global Revenue Market Share of Inhaled Asthma Medications by Application (2019-2030)

Figure 57. Global Inhaled Asthma Medications Price (US$/Unit) by Application (2019-2030)

Figure 58. Inhaled Asthma Medications Value Chain

Figure 59. Inhaled Asthma Medications Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions